Rapid Micro Biosystems (RPID) Reiterated at Buy by Stifel: Top-Line Results as Expected
Tweet Send to a Friend
Stifel analyst Daniel Arias reiterated a Buy rating and $8.00 price target on Rapid Micro Biosystems Inc (NASDAQ: RPID).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
